{"id":"0e2f5d6f-8ce6-4726-9301-d438ecf732bc","companyId":"e5127536-0ff2-4f0e-8488-64994cb2ffc7","modelName":"Ion Endoluminal System","slug":"intuitive-ion","description":"Intuitive Surgical's Ion Endoluminal System is a robotic-assisted bronchoscopy platform for minimally invasive biopsy of peripheral lung nodules. It uses an ultra-thin, shape-sensing maneuverable catheter with PlanPoint CT-based airway planning to reach lesions deep in the peripheral lung. FDA 510(k) cleared in February 2019 and commercially deployed across US hospitals, with subsequent AI and advanced-imaging integration clearances.","formFactor":"surgical","maturityStage":"commercial","lifecycleState":"active","supersededByModelId":null,"specs":{"pathway":"FDA 510(k) cleared 2019-02-20 (clearance number not corroborated to bar)","modality":"shape-sensing robotic-assisted bronchoscopy","planning":"PlanPoint CT-based airway planning","indication":"peripheral lung nodule biopsy"},"manufacturerSerial":null,"reviewStatus":"reviewed","sources":[{"url":"https://isrg.intuitive.com/news-releases/news-release-details/u-s-fda-grants-clearance-ion-intuitive/","title":"FDA grants clearance for Ion by Intuitive","sourceName":"Intuitive Surgical (official)"},{"url":"https://www.sages.org/publications/tavac/intuitive-ion-endoluminal-system/","title":"Ion Endoluminal System TAVAC","sourceName":"SAGES"}],"aliases":["Ion","Ion Endoluminal System"],"collisionRisk":"low","reviewNote":null,"manufacturerTermForTeleop":null,"createdAt":"2026-06-05T17:43:05.364Z","updatedAt":"2026-06-05T17:43:05.364Z","jsonLd":{"@context":"https://schema.org","@type":"Product","@id":"https://registry.deploy.report/models/intuitive-ion","url":"https://registry.deploy.report/models/intuitive-ion","name":"Ion Endoluminal System","alternateName":["Ion","Ion Endoluminal System"],"description":"Intuitive Surgical's Ion Endoluminal System is a robotic-assisted bronchoscopy platform for minimally invasive biopsy of peripheral lung nodules. It uses an ultra-thin, shape-sensing maneuverable catheter with PlanPoint CT-based airway planning to reach lesions deep in the peripheral lung. FDA 510(k) cleared in February 2019 and commercially deployed across US hospitals, with subsequent AI and advanced-imaging integration clearances.","identifier":"0e2f5d6f-8ce6-4726-9301-d438ecf732bc","category":"surgical","publisher":{"@id":"https://deploy.report/#organization"}},"framework_metadata":{"framework_schema_version":"0.1.0","verification_status":"verified","maturity_stage":"commercial","lifecycle_state":"active","architectural_position":{"cohort":"surgical","sub_cohorts":[]},"within_cohort_verified_vs_claimed_pair":null,"cap_flags":[],"verification_depth":{"sources_count":2,"primary_source_types":["primary-company-ir"]}}}